Breathomix has developed BreathBase®, which includes eNose technology linked to a cloud-solution that aims to transform the way patients are diagnosed and managed by enabling rapid diagnostic answers in the doctor’s office. BreathBase® is a combination of an easy-to-use eNose, SpiroNose®, and a constantly growing online reference database coupled with an AI-powered platform, which allow real-time, on-site analysis of composite exhaled biomarkers within seconds. Breathomix is committed to target unmet medical needs across a wide range of disease areas including but not limited to chronic respiratory disease, cancer & infectious diseases by developing & bringing together all the necessary elements of data-driven medicine in the era of precision medicine.
Something looks off?